Hypoalbuminemia in dialysis: Is a malnutrition or inflammation marker?;Hipoalbuminemia en diálisis. ¿Es marcador de desnutrición o de inflamación?

Revista de Investigacion Clinica

Volumn 53, Issue 2, 2001, Pages 152-158

  Manzano, Alfonso Martín Cueto ^a,b  

^a HOSPITAL DE ESPECIALIDADES   (Mexico)

^b Col Independencia ^*  (Mexico)

Author keywords

Dialysis; Hypoalbuminemia; Inflammation; Malnutrition

Indexed keywords

BIOLOGICAL MARKER; INTERLEUKIN 1; SERUM ALBUMIN; TUMOR NECROSIS FACTOR ALPHA;

BLOOD; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY FAILURE; HUMAN; INFLAMMATION; METABOLISM; MORTALITY; PERITONEAL DIALYSIS; PROGNOSIS; PROTEIN CALORIE MALNUTRITION; RENAL REPLACEMENT THERAPY; REVIEW;

BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; HUMANS; INFLAMMATION; INTERLEUKIN-1; KIDNEY FAILURE, CHRONIC; PERITONEAL DIALYSIS; PROGNOSIS; PROTEIN-ENERGY MALNUTRITION; RENAL DIALYSIS; SERUM ALBUMIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0346405122     PISSN: 00348376     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (64)

1. Marckmann P. Nutritional status and mortality of patients in regular dialysis therapy. J Intern Med 1989; 226: 429-32.
2. Schoenfeld PY, Henry RR, Laird NM, Roxe DM. Assessment of nutritional status of the National Cooperative Study Population. Kidney Int 1983; 23: 80-8.
3. Cianciaruso B, Brunori G, Kopple JD, Traverso G, Panarello G, Enia G, et al. Cross-sectional comparison of malnutrition in continuous ambulatory peritoneal dialysis and hemodialysis patients. Am J Kidney Dis 1995; 26: 475-86.
4. Young GA, Kopple JD, Lindholm B, Vonesh EF, De Vecchi A, Scalamogna A, et al. Nutritional assessment of continuous ambulatory peritoneal dialysis patients: An international study. Am J Kidney Dis 1991; 17: 462-71.
5. Espinosa MA, Cueto-Manzano AM, Velázquez-Alva C, Hernández A, Cruz N, Zamora B, et al. Prevalence of malnutrition in Mexican CAPD diabetic and non-diabetic patients. Adv Perit Dial 1996; 12: 302-6.
6. Bergström J. Why are dialysis patients malnourished? Am J Kidney Dis 1995; 26: 229-41.
7. CANADA-USA (CANUSA) Peritoneal Dialysis Study Group. Adequacy of dialysis and nutrition in continuous ambulatory peritoneal dialysis: association with clinical outcomes. J Am Soc Nephrol 1996; 7: 198-207.
8. Lowrie EG, Lew NL. Death risk in hemodialysis patients: The predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis 1990; 15: 458-82.
9. Kopple JD. Effect of nutrition on morbidity and mortality in maintenance dialysis patients. Am J Kidney Dis 1994; 24: 1002-9.
10. Maiorca R, Cancarini GC, Brunori G, Camerini C, Manili L. Morbidity and mortality of CAPD and hemodialysis. Kidney Int 1993; 43 (Suppl. 40): S4-S15.
11. Gamba G, Mejía JL, Saldívar S, Peña JC, Correa-Rotter R. Death risk in CAPD patients. Nephron 1993; 65: 23-7.
12. Bergström J. Nutrition and mortality in hemodialysis. J Am Soc Nephrol 1995; 6: 1329-41.
13. Kaysen GA, Gambertoglio Jimenez I, Jones H, Hutchison FN. Effect of dietary protein intake on albumin homeostasis in nephrotic patients. Kidney Int 1986; 29: 572-7.
14. Bistrian BR, Blackburn GL, Scrimshaw NS, Flatt JP. Cellular immunity in semistarved status in hospitalized adults. Am J Clin Nutr 1975; 28: 1148-55.
15. White RG, Coward WA, Lunn PG. Serum albumin concentration and the onset of Kwashiorkor. Lancet 1973; 1: 63-6.
16. Blackburn GL, Thomton PA. Nutritional assessment of the hospitalized patient. Med Clin North Am 1979; 63: 1103-15.
17. Blumenkrantz MJ, Kopple JD, Gutman RA, Chan YK, Barbour GL, Roberts C, et al. Methods for assessing nutritional status of patients with renal failure. Am J Clin Nutr 1980; 33: 1567-85.
18. Kaysen GA. Albumin turnover in renal disease. Miner Electrolyte Metab 1998; 24: 55-63.
19. Lindholm B, Bergström J. Nutritional requirements of peritoneal dialysis patients. En: Gokal R, Nolph KD (editores): The Textbook of Peritoneal Dialysis, Dordrecht: Kluwer Academic, 1994. p. 443-72.
20. Kaysen GA, Schoenfeld PY. Albumin homeostasis in patients undergoing continuous ambulatory peritoneal dialysis. Kidney Int 1984; 25: 107-14.
21. Cueto-Manzano AM. Cuantificación de las pérdidas proteicas en diálisis peritoneal continua ambulatoria de acuerdo al tipo de transporte de la membrana peritoneal y su modificacion con la reducción de los tiempos de estancia del dializante en la cavidad peritoneal. Tesis de Maestría en Ciencias Médicos. UNAM, 1997.
22. Harty JC, Boulton H, Venning MC, Gokal R. Is peritoneal permeability an adverse risk factor for malnutrition in CAPD patients? Miner Electrolyte Metab 1996; 22: 97-101.
23. Wanner C, Zimmermann J, Quaschning T, Galle J. Inflammation, dyslipidemia and vascular factors in hemodialysis patients. Kidney Int 1997; 52 (Suppl. 62): S53-S55.
24. Moshage HJ, Janssen JAM, Franssen JH, Hafkenscheid JCM, Yap SH. Study of the molecular mechanism of decreased liver synthesis of albumin in inflammation. J Clin Invest 1987; 79: 1635-41.
25. Bleuter B, Cerami A. Cachectin: More than a tumor necrosis factor. N Engl J Med 1987; 316: 379-85.
26. Dinarello CA. Interleukin-1 and the pathogenesis of the acute phase response. N Engl J Med 1984; 311: 1413-8.
27. Bristian B, Schwartz J, Istifan NW. Cytokines, muscle proteolysis and the catabolic response to infection and inflammation. Proc Soc Exp Biol Med 1992; 200: 220-3.
28. Herbelin A, Nguyen AT, Zinfraff J, Ureña P, Descamps-Latscha B. Influence of uremia and hemodialysis on circulating interleukin-1 and tumor necrosis a. Kidney Int 1990; 37: 116-25.
29. Le J, Vilcek J. Interleukin 6: A multifunctional cytokine regulating immune reactions and the acute phase protein response. Lab Invest 1989; 61: 588-602.
30. Memoli B, Libetta C, Rampino T, Dal Canton A, Conte G, Scala G, et al. Hemodialysis related induction of interleukin-6 production by peripheral blood mononuclear cells. Kidney Int 1992; 40: 320-6.
31. Kaysen GA, Stevenson FT, Depner TA. Determinants of albumin concentrations in hemodialyisis patients. Am J Kidney Dis 1997; 29: 658-68.
32. Docci D, Bilancioni R, Baldrati L, Capponcini C, Turci F, Feletti C. Elevated acute phase reactants in hemodialysis patients. Clin Nephrol 1990; 34: 88-91.
33. Bologa RM, Levine DM, Parker TS, Cheigh JS, Serur D, Stenzel KH, Rubin AL. Interleukin-6 predicts hypoalbuminemia, hypocholesterolemia, and mortality in hemodialysis patients. Am J Kidney Dis 1998; 32: 107-14.
34. Kaizu Y, Kimura M, Yoneyama T, Miyaji K, Hivi I, Kumagai H. Interleukin-6 may mediate malnutrition in chronic hemodialysis patients. Am J Kidney Dis 1998; 31: 93-100.
35. Qureshi AR, Alvestrand A, Danielsson A, Divino-Filho JC, Gutierrez A, Lindholm B, Bergström J. Factors predicting malnutrition in hemodialysis patients: A cross-sectional study. Kidney Int 1998; 53: 773-82.
36. Han DS, Lee SW, Kang SW, Choi KH, Lee HY, Cho EY, Lee JH. Factors affecting low values of serum albumin in CAPD patients. Adv Perit Dial 1996; 12: 288-92.
37. Blumenkrantz MJ, Kopple JD, Moran JK, Grodstein GP, Coburn JW. Nitrogen and urea metabolism during continuous ambulatory peritoneal dialysis. Kidney Int 1981; 20: 78-82.
38. Cueto-Manzano AM, Espinosa A, Hernández A, Correa-Rotter R. Peritoneal Transport Kinetics correlate with Serum Albumin but not with the Overall Nutritional Status in CAPD Patients. Am J Kidney Dis 1997; 30: 229-36.
39. Luger A, Kovarik J, Stummvoll HK, Urbanska A, Luger TA. Blood-membrane interaction in hemodialysis leads to increased cytokine production. Kidney Int 1987; 32: 84-8.
40. Kimmel PL, Phillips TM, Phillips E, Bosch JP. Effect of renal replacement therapy on cellular cytokine production in patients with renal disease. Kidney Int 1990; 38: 129-35.
41. Roccatello D, Menegatti E, Alfieri V, Rossi D, DeLuca A, Pignone E, Mengozzi G, Cesano G, Formica M, Martina G, Sena LM, Piccoli G. Intradialytic cytokine gene expression. Blood Purif 1998; 16: 30-6.
42. Stenvinkel P, Heimburger O, Tuck CH, Berglund L. Apo(a)-isoform size, nutritional status and inflammatory markers in chronic renal failure. Kidney Int 1998; 53: 1336-42.
43. CANADA-USA (CANUSA) Peritoneal Dialysis Study Group. Adequacy of dialysis and nutrition in continuous ambulatory peritoneal dialysis: Association with clinical outcomes. J Am Soc Nephrol 1996; 7: 198-207.
44. Bergström J, Heimbürger O, Lindholm B, Qureshi AR (Abstract). Elevated serum C-reactive protein is a strong predictor of increased mortality and low serum albumin in hemodialysis patients. J Am Soc Nephrol 1995; 6: 573.
45. United States Renal Data System. 1998 Annual Data Report. Am J Kidney Dis 1998; 32: S81-S88.
46. Bergström J, Lindholm B. Malnutrition, cardiac disease, and mortality: An integrated point of view. Am J Kidney Dis 1998; 32: 834-41.
47. Freeman LM, Roubenoff R. The nutrition implications of cardiac cachexia. Nutr Rev 1994; 52: 340-7.
48. Yokoyama T, Vaca L, Rossen RD, Durante W, Hazarika P, Mann DL. Cellular basis for the negative inotropic effects of tumor necrosis factor-α in the adult mammalian heart. J Clin Invest 1993; 92: 2303-12.
49. Anker SD, Ponikowski P, Varney S, Chua TP, Clark AL, Webb-Peploe KM, et al. Wasting as independent risk factor for mortality in heart failure. Lancet 1997; 349: 1050-3.
50. Levine B, Kalman J, Mayer L, Fillit HM, Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 1990; 323: 236-41.
51. Danesh J, Collins R, Peto R. Chronic infections and coronary heart disease: Is there a link? Lancet 1997; 350: 430-6.
52. Cressman MD, Heyka RJ, Paganini EP, O'Neal J, Skibinski CI, Hoff HF. Lipoprotein (a) is an independent risk factor for cardiovascular disease in hemodialysis patients. Circulation 1992; 86: 475-82.
53. Biasucci LM, Vitelli A, Luizzo G, Altamura S, Caligiuri G, Monaco C, et al. Elevated levels of interleukin-6 in unstable angina. Circulation 1996; 94: 874-7.
54. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997; 336: 973-9.
55. Coles GA. Body composition in chronic renal failure. QMJ 1972; 41: 25-47.
56. May RC, Kelly RA, Mitch WE. Mechanisms for defects in muscle protein metabolism in rats with chronic uremia. Influence of metabolic acidosis. J Clin Invest 1987; 79: 1099-103.
57. Bailey JL, Wang X, England BK, Price SR, Ding X, Mitch WE. The acidosis of chronic renal failure activates muscle proteolysis in rats by augmenting transcription of genes encoding proteins of the ATP-dependent ubiquitin-proteasome pathway. J Clin Invest 1996; 97: 1447-53.
58. Kaysen GA, Rathore V, Shearer GC, Depner TA. Mechanisms of hypoalbuminemia in hemodialysis patients. Kidney Int 1995; 48: 510-6.
59. Gutierrez A, Alvestrand A, Wahren J, Bergström J. Effect of in vivo contact between blood and dialysis membranes on protein catabolism in humans. Kidney Int 1990; 38: 487-94.
60. Kaysen GA, Watson JB. Mechanism of hypoalbuminemia in the 7/ 8-nephrectomized rat with chronic renal failure. Am J Physiol 1982; 243: F372-F378.
61. Twardowski ZJ, Nolph KD, Khanna R, Prowant BF, Ryan LP, Moore HL, Nielsen MP. Peritoneal equilibration test. Perit Dial Bull 1987; 7: 138-47.
62. Parving HH, Gyntelberg F. Transcapillary escape rate of albumin and plasma volume in essential hypertension. Circ Res 1973; 32: 643-51.
63. Parving HH, Rasmussen M. Transcapillary escape rate of albumin and plasma volume in short-and long-term juvenile diabetes. Scand J Clin Lab Invest 1973; 32: 81-7.
64. Ballmer PE, Achsenbein AF, Schütz-Hofmann S. Transcapillary escape rate of albumin positively correlates with plasma albumin concentration in acute but not in chronic inflammatory disease. Metabolism 1994; 43: 697-705.